112 related articles for article (PubMed ID: 11903188)
21. Decreased uptake of therapeutic doses of iodine-131 after 185-MBq iodine-131 diagnostic imaging for thyroid remnants in differentiated thyroid carcinoma.
Leger FA; Izembart M; Dagousset F; Barritault L; Baillet G; Chevalier A; Clerc J
Eur J Nucl Med; 1998 Mar; 25(3):242-6. PubMed ID: 9580856
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of low-dose iodine-131 ablation of post-operative thyroid remnants: a study of 69 cases.
Leung SF; Law MW; Ho SK
Br J Radiol; 1992 Oct; 65(778):905-9. PubMed ID: 1422665
[TBL] [Abstract][Full Text] [Related]
23. Thyroid carcinoma metastatic to pituitary.
Sziklas JJ; Mathews J; Spencer RP; Rosenberg RJ; Ergin MT; Bower BF
J Nucl Med; 1985 Sep; 26(9):1097. PubMed ID: 4032051
[No Abstract] [Full Text] [Related]
24. Novel use of
Parihar AS; Sood A; Kumar R; Bhusari P; Shukla J; Mittal BR
Eur J Nucl Med Mol Imaging; 2018 Sep; 45(10):1836-1837. PubMed ID: 29713764
[No Abstract] [Full Text] [Related]
25. Comparison of 99mTc-methoxyisobutyl isonitrile and 201Tl scintigraphy for detection of residual thyroid cancer after 131I ablative therapy.
Seabold JE; Gurll N; Schurrer ME; Aktay R; Kirchner PT
J Nucl Med; 1999 Sep; 40(9):1434-40. PubMed ID: 10492361
[TBL] [Abstract][Full Text] [Related]
26. Unusual radioiodine uptake caused by metallic sutures in the skull in a patient with thyroid cancer.
Modoni S; Martino G; Guerra M; Frusciante V
Clin Nucl Med; 2000 Dec; 25(12):1053-4. PubMed ID: 11129153
[No Abstract] [Full Text] [Related]
27. Tumor thrombus in the great veins from papillary carcinoma of the thyroid: 131I scan findings.
Mugunthan N; Kumar AR; Thomas P
J Clin Endocrinol Metab; 2010 Jun; 95(6):2527-8. PubMed ID: 20525903
[TBL] [Abstract][Full Text] [Related]
28. An unusual presentation of diffuse sclerosing variant of papillary thyroid carcinoma.
Regalbuto C; Tumminia A; Malandrino P; Salamone S; Pezzino V
J Endocrinol Invest; 2010 Jun; 33(6):434-5. PubMed ID: 20631495
[No Abstract] [Full Text] [Related]
29. Iodine-123 uptake in vertebral haemangiomas in a patient with papillary thyroid carcinoma.
Khan S; Dunn J; Strickland N; Al-Nahhas A
Nucl Med Rev Cent East Eur; 2008; 11(1):30-3. PubMed ID: 19173186
[TBL] [Abstract][Full Text] [Related]
30. False-positive uptake on radioiodine whole-body scan due to bronchiectasis.
Espírito Santo R; Marques P; João Bugalho M
BMJ Case Rep; 2015 Nov; 2015():. PubMed ID: 26561230
[No Abstract] [Full Text] [Related]
31. Value of combined technetium-99m hydroxy methylene diphosphonate and thallium-201 imaging in detecting bone metastases from thyroid carcinoma.
Alam MS; Takeuchi R; Kasagi K; Misaki T; Miyamoto S; Iida Y; Hidaka A; Konishi J
Thyroid; 1997 Oct; 7(5):705-12. PubMed ID: 9349573
[TBL] [Abstract][Full Text] [Related]
32. Nuclear medicine approaches in the monitoring of thyroid cancer patients.
Sergieva S; Hadjieva T; Doldurova M; Stefanova S; Dudov A
J BUON; 2006; 11(4):511-8. PubMed ID: 17309186
[TBL] [Abstract][Full Text] [Related]
33. [Atypical uptake of gallbladder as cause of False-positive iodine-131 in post-surgical removal scanning of thyroid remains].
De la Riva Pérez PA; Castro Montaño J; Iglesias Jerez R; López Muñoz N; Gil Martínez EM; Rodríguez de Quesada B
Rev Esp Med Nucl; 2007; 26(1):52-3. PubMed ID: 17286950
[No Abstract] [Full Text] [Related]
34. An unusual case of a false-positive iodine-131 whole body scan in a patient with papillary thyroid cancer.
Ceccarelli C; Pacini F; Lippi F; Pinchera A
Clin Nucl Med; 1988 Mar; 13(3):192-3. PubMed ID: 3289821
[TBL] [Abstract][Full Text] [Related]
35. Value of thyroid carcinoma imaging after therapeutic doses of radioiodine.
Balachandran S; Sayle BA
Clin Nucl Med; 1981 Apr; 6(4):162-7. PubMed ID: 7214771
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic capabilities of I-131, TI-201, and Tc-99m-MIBI scintigraphy for metastatic differentiated thyroid carcinoma after total thyroidectomy.
Fujie S; Okumura Y; Sato S; Akaki S; Katsui K; Himei K; Takemoto M; Kanazawa S
Acta Med Okayama; 2005 Jun; 59(3):99-107. PubMed ID: 16049563
[TBL] [Abstract][Full Text] [Related]
37. Incidental thyroid 99mTc-MDP uptake in a patient affected by differentiated thyroid cancer.
Albano D; Magri GC; Treglia G; Bertagna F
Nucl Med Rev Cent East Eur; 2016; 19(B):8-10. PubMed ID: 27813621
[TBL] [Abstract][Full Text] [Related]
38. [Diffuse sclerosing variant of papillary thyroid carcinoma].
Manrique Franco K; Domínguez Fernández R; Lara Capellán JI; Renedo Pascual G; Rovira Loscos A
Endocrinol Nutr; 2010 Dec; 57(10):500-2. PubMed ID: 20843752
[No Abstract] [Full Text] [Related]
39. 131I therapeutic efficacy is not influenced by stunning after diagnostic whole-body scanning.
Dam HQ; Kim SM; Lin HC; Intenzo CM
Radiology; 2004 Aug; 232(2):527-33. PubMed ID: 15286323
[TBL] [Abstract][Full Text] [Related]
40. Superiority of iodine-123 compared with iodine-131 scanning for thyroid remnants in patients with differentiated thyroid cancer.
Mandel SJ; Shankar LK; Benard F; Yamamoto A; Alavi A
Clin Nucl Med; 2001 Jan; 26(1):6-9. PubMed ID: 11139058
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
